DAFTAR PUSTAKA

1. Yaman A, Isik P, Yarali N, et al. Common complications in beta-thalassemia

patients. UHOD. 2013; 23(3): 193-9.

2. Mustafa M, Thiru A, Illzam EM, et al. Pathophysiology, clinical

manifestations, and carrier detection in thalassemia. IOSR JDMS. 2016;
15(11): 122-6.

3. Hajipour M, Soltani M, Najafifar R, et al. Complications of beta thalassemia

patients and their related factors in Iran. IJDR. 2015; 5(7): 1-6.

4. Suri D, Oberoi S. Arthropathy in haematological disorders in children. Indian

J Rheumatol. 2012; 7(1): 44-51.

5. Menteri Kesehatan RI. Keputusan Menteri Kesehatan Republik Indonesia no.

HK.01.07/MENKES/1/2018 Tentang Pedoman Nasional Pelayanan
Kedokteran Tatalaksana Thalasemia. Jakarta: Kementerian Kesehatan RI.
2018.

6. Martinoli C, Bacigalupo L, Forni GL, et al. Musculoskeletal manifestations of

chronic anemias. Seminars In Musculoskeletal Radiology. 2011; 15(3): 269-
80.

7. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010; 5(11): 1-

15.

8. Nienhuis AW, Nathan DG. Pathophysiology and clinical manifestations of the

beta-thalassemias. Cold Spring Harb Perspect Med. 2012; 2(12): 1-13.

9. Safitri R, Ernawaty J, Karim D. Hubungan Kepatuhan Tranfusi Dan Konsumsi

Kelasi Besi Terhadap Pertumbuhan Anak Dengan Thalasemia. JOM.
2015;2(2):1474-83.

10. Hamizah L, Susanah S, Rakhmilla LE. Clinical manifestations of children

with thalassemia major: clinical course one year later. AJBMS. 2017; 3(1): 11.

43
11. Brancaleoni V, Di PE, Motta I, et al. Laboratory diagnosis of thalassemia. Int J
Lab Hematol. 2016; 38: 32–40.

12. Jha R, Jha S. Beta thalassemia-review. J Pathol Nepal. 2014; 4: 663-71.

13. Vehapoglu A, Ozgurhan G, Demir AD, et al. Hematological indices for

differential diagnosis of beta thalassemia trait and iron deficiency anemia.
Anemia. 2014; 2014: 1-7.

14. Perisano C, Marzetti E, Spinelli MS, et al. Physiopathology of bone

modifications in β-thalassemia. Anemia. 2012; 2012: 1–5.

15. Brittenham GM. Iron-chelating therapy for transfusional iron overload. N

Engl J Med. 2011; 364(2): 146-56.

16. Mishra AK, Tiwari A. Iron Overload in Beta Thalassaemia Major and
Intermedia Patients. Medica. 2013; 8(4): 328-32.

17. Leecharoenkiat K, Lithanatudom P, Sornjai W, Smith DR. Iron dysregulation

in beta-thalassemia. Asian Pac J Trop Med. 2016;9(11):1035–43.

18. Kurtoglu A, Kurtoglu E. Temizkan AK. Effect of iron overload on

endocrinopathies in patients with beta-thalassemia major and intermedia.
Endokrynol Pol. 2012; 63(4): 260-3.

19. Poggiali E, Cassinerio E, Laura Z, et al. An update on iron chelation therapy.

Blood Transfus. 2012; 10: 411-22.

20. Sheth S. Iron chelation: an update. Curr Opin Hematol. 2014; 21: 1-7.

21. Taher AT, Porter J, Viprakasit V, et al. Deferasirox reduces iron overload
significantly in nontransfusion-dependent thalassemia: 1-year results from a
prospective, randomized, double-blind, placebo-controlled study. Blood. 2012;
120(5): 970-7.

44
22. Atta D, Elsonaud AA, Hesham M, et al. Frequency of musculoskeletal and
otorhinolaryngologic manifestations in children with B-thalassemia. IJAR.
2015; 3(10): 959-69.

45